News
PARIS--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, announces the launch of FibroScan 630 Expert, a high-performance elastography engine that ...
Echosens is thrilled to unveil the inaugural Liver Health Super Shaper Award, a heartfelt initiative designed to celebrate the extraordinary medical professionals who are shaping the future of ...
Echosens, the company behind the industry-leading FibroScan technology, is introducing FibroScan 630 Expert, a unique device that drives non-invasive liver disease management to the next level.
FibroScan ®, Echosens' non-invasive liver assessment technology, has played a critical role in Boehringer Ingelheim's liver disease research and continues to support two ongoing Survodutide Phase ...
WESTBOROUGH, Mass., Dec. 9, 2024 /PRNewswire/ -- Echosens, the leader in liver health, is proud to be recognized as one of the 2024 Top Places to Work in Massachusetts, earning a spot among the ...
Cathay Capital Private Equity said Wednesday it invested in Echosens. Financial terms weren't announced. FuRui Group, the seller, will retain a majority holding of 51 percent. Echosens, of France ...
Echosens, the developer of FibroScan ®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of ...
Responding to the dire need for enhanced liver health management, Echosens, the leader in liver health, is proud to announce its new next-generation FibroScan ® with Guided Vibration-Controlled ...
This initiative is in partnership with Echosens, the innovators and marketers of the FibroScan ® family of products. The NASHNet pilot evaluates an inter-disciplinary model across the care ...
Echosens announced today the appointment of Victor de Lédinghen, MD PhD, as the company's new Chief Medical Officer. With over two decades of clinical experience, Dr. de Lédinghen brings ...
Echosens SA obtained clearance from the U.S. FDA to expand the indications for screening with its Fibroscan system. The approval removes contraindications for pregnancy and active implant and includes ...
About Echosens Pioneer in its field, Echosens significantly changed the practice of liver assessment with FibroScan®, the non-invasive solution for comprehensive management of liver health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results